ArticleCancer chemotherapy and pharmacology2019

Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.

Roger M Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.